Scar tissue or lipohypertrophy areas should be avoided
Sources Wilding JPH et al., "Once-Weekly Semaglutide in Adults with Overweight or Obesity," NEJM 2021 (STEP 1 trial, 14.9% weight loss at 68 weeks) Jastreboff AM et al., "Tirzepatide Once Weekly for the Treatment of Obesity," NEJM 2022 (SURMOUNT-1 trial, up to 22.5% weight loss at 72 weeks) FDA Warning Letter Database and April 15, 2026 Federal Register action on Category 2 peptide bulk substances, FDA.gov DOJ press releases, late 2025, on criminal guilty pleas in grey-market peptide distribution cases PubMed systematic reviews, 2024-2025, on BPC-157 preclinical and clinical evidence (multiple authors
Rarely, metformin may cause potentially serious lactic acidosis, a buildup of lactic acid in the blood (Diabetes.co.uk 2016)
Certain groups might want to be more careful with BPC 157: Athletes : Regulatory concerns mean athletes should think twice
But if the deficiency is caused by an irreversible inability to absorb the vitamin, a lifelong treatment with pharmacological doses of B12 is needed
KLOW is a four-peptide research blend containing BPC-157 (10mg), TB-500 (10mg), GHK-Cu (50mg) and KPV (10mg)
